Emerging Anti-VEGF therapies and New Vitreoretinal Disease Treatments
Date: 20/03/2019
Venue: 7 Lakeside Boulevard, Pakenham, VIC, 3072
Provider: Dr Jonathan Yeoh
Contact: Jonathan Yeoh, [E] referral@retina-doctors.net, [P] (03) 96623808
Learning Objectives
- At the completion of the course participants should have an understanding of new and emerging anti-VEGF therapies in the treatment of neovascular age related macular degeneration, diabetic macular oedema and retinal vein occlusion
- The participants should be able to understand of the management of subluxed lenses with intrascleral haptic intraocular lens fixation. Also they will have gained insight into the management of large macular holes with internal limiting membrane flaps and the use of plasminogen activator injections to displace submacular haemorrhage
- At the completion of the course participants will have learnt about the artificial retina prosthesis, advances in gene therapy and stem cell therapy.
Max points awarded: 4.00
Session Information
| Name |
|---|
| Emerging Anti-VEGF therapies |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.50 |
| Name |
|---|
| Management of subluxed lenses by new haptic intraocular lens fixation technique |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.00 |
| Name |
|---|
| New treatments in Vitreoretinal disease |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.50 |
| Name | Activity Type | Therapeutic? | Manufacturer/ Supplier? | Points for attending & Passing Assessment |
|---|---|---|---|---|
| Emerging Anti-VEGF therapies | Face to Face with Assessment | No | No | 1.50 |
| Management of subluxed lenses by new haptic intraocular lens fixation technique | Face to Face with Assessment | No | No | 1.00 |
| New treatments in Vitreoretinal disease | Face to Face with Assessment | No | No | 1.50 |